BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11255453)

  • 21. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.
    Friedland RP; Budinger TF; Koss E; Ober BA
    Neurosci Lett; 1985 Feb; 53(3):235-40. PubMed ID: 3872424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
    Higuchi M; Tashiro M; Arai H; Okamura N; Hara S; Higuchi S; Itoh M; Shin RW; Trojanowski JQ; Sasaki H
    Exp Neurol; 2000 Apr; 162(2):247-56. PubMed ID: 10739631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions.
    Klupp E; Förster S; Grimmer T; Tahmasian M; Yakushev I; Sorg C; Yousefi BH; Drzezga A
    Brain Connect; 2014 Jun; 4(5):371-83. PubMed ID: 24870443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topography of callosal atrophy reflects distribution of regional cerebral volume reduction in Alzheimer's disease.
    Pantel J; Schröder J; Jauss M; Essig M; Minakaran R; Schönknecht P; Schneider G; Schad LR; Knopp MV
    Psychiatry Res; 1999 Jun; 90(3):181-92. PubMed ID: 10466737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's deterioration in intellectual and neurobiological staging supports the retrogenesis model: a double dissociation between verbal/non-verbal judgments and the left/right parieto-temporal glucose metabolism. A retrospective data analysis from the Tajiri Project.
    Meguro M; Meguro K; Takahashi K; Yamaguchi S; Tashiro M
    Psychogeriatrics; 2020 Mar; 20(2):149-155. PubMed ID: 31456337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frontotemporal dementia and Alzheimer disease: evaluation of cortical atrophy with automated hemispheric surface display generated with MR images.
    Kitagaki H; Mori E; Yamaji S; Ishii K; Hirono N; Kobashi S; Hata Y
    Radiology; 1998 Aug; 208(2):431-9. PubMed ID: 9680572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer's Disease.
    Samuraki M; Matsunari I; Yoshita M; Shima K; Noguchi-Shinohara M; Hamaguchi T; Ono K; Yamada M
    J Alzheimers Dis; 2015; 48(2):517-28. PubMed ID: 26402015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal brain glucose metabolism in the delusional misidentification syndromes: a positron emission tomography study in Alzheimer disease.
    Mentis MJ; Weinstein EA; Horwitz B; McIntosh AR; Pietrini P; Alexander GE; Furey M; Murphy DG
    Biol Psychiatry; 1995 Oct; 38(7):438-49. PubMed ID: 8672604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease.
    Schapiro MB; Pietrini P; Grady CL; Ball MJ; DeCarli C; Kumar A; Kaye JA; Haxby JV
    J Neurol Neurosurg Psychiatry; 1993 Aug; 56(8):859-64. PubMed ID: 8350100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
    J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease.
    Kljajevic V; Grothe MJ; Ewers M; Teipel S;
    Neurobiol Aging; 2014 Sep; 35(9):1973-81. PubMed ID: 24811241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD.
    Desikan RS; Fischl B; Cabral HJ; Kemper TL; Guttmann CR; Blacker D; Hyman BT; Albert MS; Killiany RJ
    Neurology; 2008 Sep; 71(11):819-25. PubMed ID: 18672473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia.
    Boxer AL; Rankin KP; Miller BL; Schuff N; Weiner M; Gorno-Tempini ML; Rosen HJ
    Arch Neurol; 2003 Jul; 60(7):949-56. PubMed ID: 12873851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDG PET imaging in patients with pathologically verified dementia.
    Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE
    J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging.
    Murphy DG; DeCarli C; McIntosh AR; Daly E; Mentis MJ; Pietrini P; Szczepanik J; Schapiro MB; Grady CL; Horwitz B; Rapoport SI
    Arch Gen Psychiatry; 1996 Jul; 53(7):585-94. PubMed ID: 8660125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posterior cortical atrophy: variant of Alzheimer's disease? A case series with PET findings.
    Schmidtke K; Hüll M; Talazko J
    J Neurol; 2005 Jan; 252(1):27-35. PubMed ID: 15654552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease.
    Horwitz B; Grady CL; Schlageter NL; Duara R; Rapoport SI
    Brain Res; 1987 Mar; 407(2):294-306. PubMed ID: 3494486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET.
    Nestor PJ; Caine D; Fryer TD; Clarke J; Hodges JR
    J Neurol Neurosurg Psychiatry; 2003 Nov; 74(11):1521-9. PubMed ID: 14617709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.